Brief: Sprint Bioscience Q1 Operating Loss Widens To SEK 13.0 Mln

Sprint Bioscience AB

12/05/2021 06:37

May 12 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q1 NET SALES AMOUNTED TO SEK 0 (5.4) MILLION
    * Q1 OPERATING PROFIT AMOUNTED TO SEK -13.0 (-9.5) MILLION
    * Q1 PROFIT AFTER TAX AMOUNTED TO SEK -13.7 (-9.8) MILLION
    * OUTLOOK 2021: NO FORECAST IS PROVIDED

Source text for Eikon:  ID:nWkr7lb5hl 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))